N/A
Completed N=52
Protocol for the Evaluation of Dario™ BGMS Performance at Elevated Altitude
Source: ClinicalTrials.gov NCT02352298 ↗Enrolled (actual)
52
Serious AEs
0.0%
Results posted
Jun 2017
Primary outcomePrimary: Dario Blood Glucose Monitoring System Accuracy at High Altitude (ISO 15197:2003) — 28.6; 71.4; 100; 32.5 percentage of participants
Summary
The purpose of this study is to assess the performance of the Dario Blood Glucose Monitor (BGMS), at elevated altitudes, by obtaining whole blood fingerstick samples from individuals and analyzing the blood on the Dario Blood Glucose Monitor (BGMS) and comparing the readings to readings obtained from the YSI 2300 STAT Plus glucose analyzer.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Dario Blood Glucose Monitoring System Accuracy at High Altitude (ISO 15197:2003) |
28.6; 71.4; 100; 32.5; 60.1; 87.6 | — |
Eligibility Criteria
Inclusion Criteria
- Age of subject is 18 years or older
- Able to speak and read English
Exclusion Criteria
- Pregnant
- Has any condition that the principal investigator believes may interfere in the subject's participation in the trial.
Data sourced from ClinicalTrials.gov (NCT02352298). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.